scholarly journals Sulfamethoxazole stone in a patient with extensive history of urolithiasis and recurrent urinary tract infections

2021 ◽  
pp. 101812
Author(s):  
Abbie M. Chase ◽  
Laena Hines ◽  
Elizabeth Ellis ◽  
Rajat Jain ◽  
Scott O. Quarrier
Urology ◽  
2013 ◽  
Vol 81 (2) ◽  
pp. 221-225 ◽  
Author(s):  
David C. Moore ◽  
Kirk A. Keegan ◽  
Matthew J. Resnick ◽  
Rosana Eisenberg ◽  
Ginger E. Holt ◽  
...  

2019 ◽  
Vol 2019 ◽  
pp. 1-2
Author(s):  
Masashi Takemaru ◽  
Noriko Aramaki-Hattori ◽  
Chisato Tsue ◽  
Kazuo Kishi

A 91-year-old postmenopausal woman with a prior history of two labial-adhesion separations suffered from recurrent urinary-tract infections. We were able to successfully treat her labial adhesions using surgery.


2019 ◽  
Vol 19 (1) ◽  
Author(s):  
Cristóbal Ramírez Sevilla ◽  
Esther Gómez Lanza ◽  
Juan Llopis Manzanera ◽  
Jose Antonio Romero Martín ◽  
Miguel Ángel Barranco Sanz

Abstract Background To prospectively analyze the efficacy of uromune® in the prevention of uncomplicated recurrent urinary tract infections at 3 and 6 months, and according to gender and menopause. Methods From September 2011 to December 2017 uromune® was administered sublingually every 24 h along 3 months to 784 patients with history of three or more uncomplicated urinary tract infections in the 12 months prior to the first visit. The variables analyzed with statistical package system for science version 15.0 were age, gender, number of urinary tract infections with positive urine culture in the first consultation, and 3 and 6 months after the end of treatment. The results with positive urine culture were registered at 3 and 6 months after the end of the treatment according to gender and also in the menopausal group with respect to pre-menopausal women. Results Mean age was 73.5 years. 82.7% were women and 94.3% menopausal. The number of episodes of urinary tract infections in the 12 months prior to uromune® were 3 in 37.2%, 4 in 28.1%, 5 in 19.5%, 6 in 9.6%, 7 in 4%, 8 in 1.4%, 9 in 0.1% and 10 in 0.1%. Three months after uromune® 44.1% had 0 urinary tract infections and 27.6% had 1. After 6 months the results were 0 urinary tract infections in 32.3% and 1 in 32.4%. Women had 0 urinary tract infections after 3 months in 45.4% and 1 in 28.5%. At 6 months the female had 0 episodes in 32.7% and 1 in 33.2%. Menopausal women had 0 urinary tract infections at 3 months in 46.5% and 1 in 28% and at 6 months scored 0 episodes in 33.6% and 1 in 32.9%. Conclusions Uromune® was highly effective to reduce the number of episodes of urinary tract infections at three and six months of follow-up. Uromune® reduced the number of episodes to zero or one in 71.7 and 64.7% at three and six months with minimal side effects. The best results were observed in women over 50 years old. Sublingual immunoprophylaxis with uromune® could be the treatment of first choice in the prevention of uncomplicated recurrent urinary tract infections according to the sample analyzed.


2021 ◽  
Vol 15 (1) ◽  
Author(s):  
Hussam S. Khougali ◽  
Omer Ali Mohamed Ahmed Alawad ◽  
Nicholas Farkas ◽  
Mohammed Mahgoub Mirghani Ahmed ◽  
Alnasri Mohammed Abuagla

Abstract Background The incidence of ectopic kidneys is 1:12,000 clinically and 1:900 postmortem. Patients with pelvic mal-rotated kidneys are more susceptible to recurrent urinary tract infections, recurrent renal stones, and renal injury. Fusion of the kidney lower poles is relatively common compared to other types of renal anomalies. Case presentation We present the case of a 36-year-old Sudanese female patient who presented with a long history of recurrent urinary tract infections unresponsive to antibiotics. Ultrasound scan revealed bilateral pelvic kidneys. Computed tomography (CT) urography confirmed bilateral ectopic fused kidneys, with the left kidney mal-rotated (renal pelvis facing upwards and laterally). Kidney infection secondary to vesicoureteral reflux was diagnosed. Antibiotics were prescribed according to culture and sensitivity. The patient responded well to ciprofloxacin. Conclusion A history of recurrent urinary tract infections without an apparent cause is highly suggestive of renal anomaly and should be investigated expediently. Ultrasonography or CT imaging may be utilized to aid in diagnosis. Early recognition may help prevent the high risk of end-stage renal failure associated with anomalies.


2013 ◽  
Vol 6 (4) ◽  
pp. 150 ◽  
Author(s):  
Michael Czerwinski ◽  
Sumit Dave

Inflammatory myofibroblastic tumours (IMTs) have been describedin lung, bladder, spleen, breast, pancreas, liver, colon, spermaticcord, prostate, peripheral nerves, orbit and kidney. Traditionallybelieved as having a reactive pathogenesis, IMTs are now viewedmore as a neoplasm. This report describes a case of a renal IMT ina 14-year-old girl with spina bifida associated neurogenic bladderand a history of recurrent urinary tract infections. This represents aunique case as pediatric renal IMTs are very rare in the literature.We discuss how this patient was managed and how she presented compared to other reported cases.


Sign in / Sign up

Export Citation Format

Share Document